Protection against lethal polyomicrobial al sepsis CNI-1493, an inhibitor of pro-inflammatory cytokine synthesis

Journal of Endotoxin Research

Volumn 4, Issue 3, 1997, Pages 197-204

  Villa, P ^a,b   Meazza, C ^a   Sironi, M ^a   Bianchi, M ^c   Ulrich, P ^c   Botchkina, G ^c   Tracey, K J ^c,d   Ghezzi, P ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CNR   (Italy)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; CYTOKINE; GENTAMICIN; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; SEMAPIMOD; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; IMMUNOREGULATION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG DISEASE; MOUSE; NONHUMAN; POSTOPERATIVE INFECTION; SEPSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030795835     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400305     Document Type: Article

References (31)

1. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477.
2. Windsor A.C.J., Walsh C.J., Mullen P.G., et al. Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 1993; 91: 1459-1468.
3. Tracey K.J. Tumor necrosis factor alpha. In: Thomson A.W. Ed The Cytokine Handbook, 2nd edn. New York: Academic Press, 1994; 289-304.
4. Saez-Llorens X., McCracken G.H. Sepsis syndrome and septic shock in pediatrics: current concept of terminology, pathophysiology, and management. J Pediatr 1993; 123: 497-508.
5. Abraham E., Wunderink R., Silverman H., et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome. JAMA 1995; 273: 934-941.
6. Fisher C.J. et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996; 334: 1697-1702.
7. Fisher C.J. et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994; 271: 1836-1843.
8. Zeni F., Pain P., Vindimian M., et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207-214.
9. Waage A., Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 1988; 167: 1987-1992.
10. Vogel S.N., Kaufman E.N., Tate M.D., Neta R. Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 1988; 56: 2650-2657.
11. Bianchi M., Ulrich P., Bloom O., et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med 1995; 1: 254-266.
12. Bianchi M., Bloom O., Raabe T., et al. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 1996; 183: 927-936.
13. Cohen P.S., Nakshatri H., Dennis J., et al. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci USA 1996; 93: 3967-3971.
14. Cohen P.S., Schmidtmayerova H., Dennis J. et al. The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 1997; 3: 339-346.
15. Baker C.C., Chaudri I.H., Gaines H.O., Baue A.E. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331-335.
16. Villa P., Sartor G., Angelini M., et al. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immun 1995; 2: 549-553.
17. Goya T., Abe M., Shimura H., Torisu M. Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol 1992; 52: 236-243.
18. Echtenacher B., Falk W., Mannel D.N., Krammer P.H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145: 3762-3766.
19. Goldblum S.E., Wu K.M., Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 1985; 59: 1978-1985.
20. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
21. Uchiba M., Okajima K., Murakami K., Okabe H., Takatsuki K. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 1995; 78: 117-125.
22. Stephens K.E., Ishizaka A., Larrick J.W., Raffin T.A. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis 1988; 137: 1364-1370.
23. Gibbs L.S., Lai L., Malik A.B. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J Cell Physiol 1990; 145: 496-500.
24. Lundblad R., Ekstrom P., Giercksky K.E. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock 1995; 3: 210-215.
25. Remick D., Manohar P., Bolgos G., Rodriguez J., Moldawer L., Wollenberg G. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 1995; 4: 89-95.
26. Mantovani A, Bussolino E, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 2591-2599.
27. Badolato R., Johnston J.A., Wang J.M., et al. Serum amyloid A induces calcium mobilization and chemafaxis of human myocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 1995; 155: 4004-4010.
28. Gadina M., Bertini R., Mengozzi M., Zandalasini M., Mantovani A, Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 1991; 173: 1305-1310.
29. Sironi M., Gadina M., Kankova M., et al. Differential sensitivity of in vivo TNF and IL-6 production to modulation by antiinflammatory drugs in mice. Int J Immunopharmacol 1992; 14: 1045-1050.
30. Sipe J.D., Gonnerman W.A., Loose L.D., Knapschaefer G., Xie W.J., Franzblau C. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J Immunol Methods 1989; 125: 125-135.
31. Tracey W.R., Tse J., Carter G. lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Phannacol Exp Ther 1995; 272: 1011-1015.